25 XP   0   0   10

Neuroscientific Biopharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyse Neuroscientific together

PenkeI guess you are interested in Neuroscientific Biopharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Neuroscientific Biopharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Neuroscientific Biopharmaceuticals Ltd

I send you an email if I find something interesting about Neuroscientific Biopharmaceuticals Ltd.

Quick analysis of Neuroscientific (30 sec.)










What can you expect buying and holding a share of Neuroscientific? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.03
Expected worth in 1 year
A$0.01
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
A$-0.02
Return On Investment
-43.1%

For what price can you sell your share?

Current Price per Share
A$0.05
Expected price per share
A$0.054 - A$0.071
How sure are you?
50%

1. Valuation of Neuroscientific (5 min.)




Live pricePrice per Share (EOD)

A$0.05

Intrinsic Value Per Share

A$-0.20 - A$-0.24

Total Value Per Share

A$-0.17 - A$-0.20

2. Growth of Neuroscientific (5 min.)




Is Neuroscientific growing?

Current yearPrevious yearGrowGrow %
How rich?$3m$3.5m-$530.4k-17.6%

How much money is Neuroscientific making?

Current yearPrevious yearGrowGrow %
Making money-$686.3k-$6.7m$6m876.5%
Net Profit Margin-21.6%-15,245.2%--

How much money comes from the company's main activities?

3. Financial Health of Neuroscientific (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#802 / 1016

Most Revenue
#394 / 1016

Most Profit
#217 / 1016

Most Efficient
#499 / 1016

What can you expect buying and holding a share of Neuroscientific? (5 min.)

Welcome investor! Neuroscientific's management wants to use your money to grow the business. In return you get a share of Neuroscientific.

What can you expect buying and holding a share of Neuroscientific?

First you should know what it really means to hold a share of Neuroscientific. And how you can make/lose money.

Speculation

The Price per Share of Neuroscientific is A$0.053. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neuroscientific.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neuroscientific, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.03. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neuroscientific.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-9.0%0.00-9.0%-0.05-87.5%-0.02-32.2%-0.01-21.5%
Usd Book Value Change Per Share0.00-6.9%0.00-6.9%-0.04-76.1%0.006.6%0.004.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-6.9%0.00-6.9%-0.04-76.1%0.006.6%0.004.9%
Usd Price Per Share0.05-0.05-0.12-0.12-0.07-
Price to Earnings Ratio-10.83--10.83--2.49--10.16--6.35-
Price-to-Total Gains Ratio-14.01--14.01--2.87--5.41--5.41-
Price to Book Ratio2.46-2.46-4.72-4.43-2.77-
Price-to-Total Gains Ratio-14.01--14.01--2.87--5.41--5.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0340419
Number of shares29375
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (29375 shares)-107.76103.37
Gains per Year (29375 shares)-431.02413.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-431-4410413403
20-862-8720827816
30-1293-1303012401229
40-1724-1734016541642
50-2155-2165020672055
60-2586-2596024812468
70-3017-3027028942881
80-3448-3458033083294
90-3879-3889037213707
100-4310-4320041354120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.08.00.00.0%0.08.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.03.00.062.5%5.03.00.062.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.03.00.062.5%5.03.00.062.5%

Fundamentals of Neuroscientific

About Neuroscientific Biopharmaceuticals Ltd

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. The company's lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. It was incorporated in 2002 and is based in Cottesloe, Australia.

Fundamental data was last updated by Penke on 2024-04-02 03:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Neuroscientific Biopharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neuroscientific earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Net Profit Margin of -21.6% means that $-0.22 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -21.6%. The company is making a huge loss. -2
  • The TTM is -21.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21.6%TTM-21.6%0.0%
TTM-21.6%YOY-15,245.2%+15,223.6%
TTM-21.6%5Y-4,130.0%+4,108.4%
5Y-4,130.0%10Y-46,141.6%+42,011.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.6%-197.2%+175.6%
TTM-21.6%-210.4%+188.8%
YOY-15,245.2%-279.3%-14,965.9%
5Y-4,130.0%-436.8%-3,693.2%
10Y-46,141.6%-599.3%-45,542.3%
1.1.2. Return on Assets

Shows how efficient Neuroscientific is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • -20.2% Return on Assets means that Neuroscientific generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -20.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -20.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.2%TTM-20.2%0.0%
TTM-20.2%YOY-134.9%+114.7%
TTM-20.2%5Y-56.7%+36.5%
5Y-56.7%10Y-60.7%+4.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.2%-13.6%-6.6%
TTM-20.2%-12.9%-7.3%
YOY-134.9%-11.9%-123.0%
5Y-56.7%-14.2%-42.5%
10Y-60.7%-16.2%-44.5%
1.1.3. Return on Equity

Shows how efficient Neuroscientific is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • -22.8% Return on Equity means Neuroscientific generated $-0.23 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -22.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -22.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.8%TTM-22.8%0.0%
TTM-22.8%YOY-189.1%+166.3%
TTM-22.8%5Y-68.5%+45.8%
5Y-68.5%10Y-75.2%+6.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.8%-17.0%-5.8%
TTM-22.8%-16.1%-6.7%
YOY-189.1%-15.4%-173.7%
5Y-68.5%-20.0%-48.5%
10Y-75.2%-21.1%-54.1%

1.2. Operating Efficiency of Neuroscientific Biopharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neuroscientific is operating .

  • Measures how much profit Neuroscientific makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • An Operating Margin of -123.7% means the company generated $-1.24  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is -123.7%. The company is operating very inefficient. -2
  • The TTM is -123.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-123.7%TTM-123.7%0.0%
TTM-123.7%YOY-15,345.2%+15,221.6%
TTM-123.7%5Y-4,251.3%+4,127.7%
5Y-4,251.3%10Y-46,083.3%+41,832.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-123.7%-286.1%+162.4%
TTM-123.7%-224.4%+100.7%
YOY-15,345.2%-288.4%-15,056.8%
5Y-4,251.3%-475.2%-3,776.1%
10Y-46,083.3%-624.7%-45,458.6%
1.2.2. Operating Ratio

Measures how efficient Neuroscientific is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are $1.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 1.237. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.237. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.237TTM1.2370.000
TTM1.237YOY153.452-152.216
TTM1.2375Y42.597-41.360
5Y42.59710Y944.698-902.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2372.997-1.760
TTM1.2373.247-2.010
YOY153.4523.766+149.686
5Y42.5975.675+36.922
10Y944.6987.857+936.841

1.3. Liquidity of Neuroscientific Biopharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neuroscientific is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.39 means the company has $8.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 8.387. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.387. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.387TTM8.3870.000
TTM8.387YOY3.336+5.051
TTM8.3875Y37.573-29.186
5Y37.57310Y24.618+12.955
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3873.930+4.457
TTM8.3874.251+4.136
YOY3.3365.436-2.100
5Y37.5736.045+31.528
10Y24.6186.363+18.255
1.3.2. Quick Ratio

Measures if Neuroscientific is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Quick Ratio of 8.30 means the company can pay off $8.30 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 8.295. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 8.295. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.295TTM8.2950.000
TTM8.295YOY3.308+4.987
TTM8.2955Y37.356-29.061
5Y37.35610Y24.030+13.327
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.2953.629+4.666
TTM8.2954.065+4.230
YOY3.3085.397-2.089
5Y37.3565.993+31.363
10Y24.0306.277+17.753

1.4. Solvency of Neuroscientific Biopharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neuroscientific assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neuroscientific to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Neuroscientific assets are financed with 11.3% credit (debt) and the remaining percentage (100% - 11.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 0.113. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.113. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.1130.000
TTM0.113YOY0.287-0.174
TTM0.1135Y0.090+0.023
5Y0.09010Y0.139-0.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1130.332-0.219
TTM0.1130.334-0.221
YOY0.2870.268+0.019
5Y0.0900.366-0.276
10Y0.1390.390-0.251
1.4.2. Debt to Equity Ratio

Measures if Neuroscientific is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neuroscientific to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.7% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The MRQ is 0.127. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.127. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.127TTM0.1270.000
TTM0.127YOY0.402-0.275
TTM0.1275Y0.116+0.011
5Y0.11610Y0.218-0.102
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1270.381-0.254
TTM0.1270.390-0.263
YOY0.4020.334+0.068
5Y0.1160.434-0.318
10Y0.2180.466-0.248

2. Market Valuation of Neuroscientific Biopharmaceuticals Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neuroscientific generates.

  • Above 15 is considered overpriced but always compare Neuroscientific to the Biotechnology industry mean.
  • A PE ratio of -10.83 means the investor is paying $-10.83 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The EOD is -7.172. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.826. Based on the earnings, the company is expensive. -2
  • The TTM is -10.826. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.172MRQ-10.826+3.654
MRQ-10.826TTM-10.8260.000
TTM-10.826YOY-2.494-8.331
TTM-10.8265Y-10.156-0.669
5Y-10.15610Y-6.348-3.809
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.172-2.315-4.857
MRQ-10.826-2.560-8.266
TTM-10.826-2.664-8.162
YOY-2.494-4.122+1.628
5Y-10.156-6.258-3.898
10Y-6.348-6.108-0.240
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The EOD is -3.326. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.020. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.020. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.326MRQ-5.020+1.694
MRQ-5.020TTM-5.0200.000
TTM-5.020YOY-3.747-1.273
TTM-5.0205Y-227.641+222.620
5Y-227.64110Y-142.275-85.365
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.326-3.067-0.259
MRQ-5.020-3.251-1.769
TTM-5.020-3.545-1.475
YOY-3.747-5.595+1.848
5Y-227.641-8.315-219.326
10Y-142.275-8.708-133.567
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neuroscientific is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.46 means the investor is paying $2.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Neuroscientific Biopharmaceuticals Ltd:

  • The EOD is 1.633. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.465. Based on the equity, the company is underpriced. +1
  • The TTM is 2.465. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.633MRQ2.465-0.832
MRQ2.465TTM2.4650.000
TTM2.465YOY4.716-2.251
TTM2.4655Y4.434-1.969
5Y4.43410Y2.771+1.663
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6331.905-0.272
MRQ2.4652.111+0.354
TTM2.4652.095+0.370
YOY4.7162.836+1.880
5Y4.4343.443+0.991
10Y2.7713.794-1.023
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Neuroscientific Biopharmaceuticals Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Neuroscientific Biopharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.0060%-0.063+1000%0.005-204%0.004-241%
Book Value Per Share--0.0320.0320%0.038-15%0.046-30%0.030+8%
Current Ratio--8.3878.3870%3.336+151%37.573-78%24.618-66%
Debt To Asset Ratio--0.1130.1130%0.287-61%0.090+25%0.139-19%
Debt To Equity Ratio--0.1270.1270%0.402-68%0.116+10%0.218-42%
Dividend Per Share----0%-0%-0%-0%
Eps---0.007-0.0070%-0.072+877%-0.027+260%-0.018+140%
Free Cash Flow Per Share---0.016-0.0160%-0.048+201%-0.020+23%-0.020+23%
Free Cash Flow To Equity Per Share---0.016-0.0160%-0.048+201%0.009-285%0.009-285%
Gross Profit Margin--1.0851.0850%1.013+7%1.032+5%1.020+6%
Intrinsic Value_10Y_max---0.236--------
Intrinsic Value_10Y_min---0.203--------
Intrinsic Value_1Y_max---0.027--------
Intrinsic Value_1Y_min---0.026--------
Intrinsic Value_3Y_max---0.078--------
Intrinsic Value_3Y_min---0.073--------
Intrinsic Value_5Y_max---0.126--------
Intrinsic Value_5Y_min---0.116--------
Market Cap7664064.576-51%11568399.36011568399.3600%26028898.560-56%26896528.512-57%16810330.320-31%
Net Profit Margin---0.216-0.2160%-152.452+70561%-41.300+19042%-461.416+213765%
Operating Margin---1.237-1.2370%-153.452+12310%-42.513+3338%-460.833+37169%
Operating Ratio--1.2371.2370%153.452-99%42.597-97%944.698-100%
Pb Ratio1.633-51%2.4652.4650%4.716-48%4.434-44%2.771-11%
Pe Ratio-7.172+34%-10.826-10.8260%-2.494-77%-10.156-6%-6.348-41%
Price Per Share0.053-51%0.0800.0800%0.180-56%0.186-57%0.116-31%
Price To Free Cash Flow Ratio-3.326+34%-5.020-5.0200%-3.747-25%-227.641+4434%-142.275+2734%
Price To Total Gains Ratio-9.280+34%-14.008-14.0080%-2.865-80%-5.414-61%-5.414-61%
Quick Ratio--8.2958.2950%3.308+151%37.356-78%24.030-65%
Return On Assets---0.202-0.2020%-1.349+568%-0.567+181%-0.607+200%
Return On Equity---0.228-0.2280%-1.891+730%-0.685+201%-0.752+230%
Total Gains Per Share---0.006-0.0060%-0.063+1000%0.005-204%0.004-241%
Usd Book Value--3014812.3253014812.3250%3545261.561-15%4306939.310-30%2803659.090+8%
Usd Book Value Change Per Share---0.004-0.0040%-0.040+1000%0.004-204%0.003-241%
Usd Book Value Per Share--0.0210.0210%0.025-15%0.030-30%0.019+8%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.0050%-0.046+877%-0.017+260%-0.011+140%
Usd Free Cash Flow---1480077.582-1480077.5820%-4461543.618+201%-1822162.194+23%-1138851.371-23%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.031+201%-0.013+23%-0.013+23%
Usd Free Cash Flow To Equity Per Share---0.010-0.0100%-0.031+201%0.006-285%0.006-285%
Usd Market Cap4922628.677-51%7430382.9097430382.9090%16718361.545-56%17275640.263-57%10797275.165-31%
Usd Price Per Share0.034-51%0.0510.0510%0.116-56%0.119-57%0.075-31%
Usd Profit---686365.634-686365.6340%-6702624.663+877%-2452293.821+257%-1636730.618+138%
Usd Revenue--3181285.5663181285.5660%43965.435+7136%793335.303+301%501265.211+535%
Usd Total Gains Per Share---0.004-0.0040%-0.040+1000%0.004-204%0.003-241%
 EOD+3 -5MRQTTM+0 -0YOY+27 -75Y+16 -1810Y+20 -14

4.2. Fundamental Score

Let's check the fundamental score of Neuroscientific Biopharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.172
Price to Book Ratio (EOD)Between0-11.633
Net Profit Margin (MRQ)Greater than0-0.216
Operating Margin (MRQ)Greater than0-1.237
Quick Ratio (MRQ)Greater than18.295
Current Ratio (MRQ)Greater than18.387
Debt to Asset Ratio (MRQ)Less than10.113
Debt to Equity Ratio (MRQ)Less than10.127
Return on Equity (MRQ)Greater than0.15-0.228
Return on Assets (MRQ)Greater than0.05-0.202
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Neuroscientific Biopharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.058
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets5,291
Total Liabilities597
Total Stockholder Equity4,694
 As reported
Total Liabilities 597
Total Stockholder Equity+ 4,694
Total Assets = 5,291

Assets

Total Assets5,291
Total Current Assets5,010
Long-term Assets281
Total Current Assets
Cash And Cash Equivalents 4,912
Net Receivables 43
Other Current Assets 55
Total Current Assets  (as reported)5,010
Total Current Assets  (calculated)5,010
+/-0
Long-term Assets
Property Plant Equipment 9
Intangible Assets 272
Other Assets 0
Long-term Assets  (as reported)281
Long-term Assets  (calculated)281
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities597
Long-term Liabilities0
Total Stockholder Equity4,694
Total Current Liabilities
Accounts payable 586
Other Current Liabilities 12
Total Current Liabilities  (as reported)597
Total Current Liabilities  (calculated)597
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock25,275
Retained Earnings -22,988
Other Stockholders Equity 2,408
Total Stockholder Equity (as reported)4,694
Total Stockholder Equity (calculated)4,694
+/-0
Other
Capital Stock25,275
Cash and Short Term Investments 4,912
Common Stock Shares Outstanding 143,472
Liabilities and Stockholders Equity 5,291
Net Debt -4,912
Net Invested Capital 4,694
Net Tangible Assets 4,421
Net Working Capital 4,412
Property Plant and Equipment Gross 9



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-30
> Total Assets 
0
247
579
809
5,123
3,738
14,827
7,737
5,291
5,2917,73714,8273,7385,1238095792470
   > Total Current Assets 
0
187
164
287
4,637
3,306
14,427
7,398
5,010
5,0107,39814,4273,3064,6372871641870
       Cash And Cash Equivalents 
63
5
126
104
4,610
3,287
14,162
7,216
4,912
4,9127,21614,1623,2874,610104126563
       Net Receivables 
0
0
38
20
28
19
49
121
43
43121491928203800
       Other Current Assets 
0
0
0
163
0
0
216
61
55
556121600163000
   > Long-term Assets 
0
0
0
0
486
432
400
339
281
2813394004324860000
       Property Plant Equipment 
0
0
0
0
14
9
28
17
9
917289140000
       Intangible Assets 
0
60
415
522
472
422
372
322
272
272322372422472522415600
       Other Assets 
0
0
0
0
0
0
0
0
0
000000000
> Total Liabilities 
0
122
43
76
62
89
223
2,218
597
5972,218223896276431220
   > Total Current Liabilities 
0
122
43
76
62
89
223
2,218
597
5972,218223896276431220
       Accounts payable 
0
0
43
21
43
62
176
2,166
586
5862,1661766243214300
       Other Current Liabilities 
0
0
0
55
19
27
48
52
12
125248271955000
   > Long-term Liabilities 
0
0
0
0
43
62
176
2,166
0
02,16617662430000
> Total Stockholder Equity
0
124
536
733
5,061
3,649
14,604
5,520
4,694
4,6945,52014,6043,6495,0617335361240
   Common Stock
0
3,551
4,224
4,814
10,707
11,716
25,275
25,275
25,275
25,27525,27525,27511,71610,7074,8144,2243,5510
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
636
1,084
1,505
2,843
2,408
2,4082,8431,5051,0846360000
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
3
541
636
1,084
1,505
2,843
2,408
2,4082,8431,5051,084636541300



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue4,953
Cost of Revenue-58
Gross Profit4,8954,895
 
Operating Income (+$)
Gross Profit4,895
Operating Expense-6,067
Operating Income-6,124-1,171
 
Operating Expense (+$)
Research Development4,026
Selling General Administrative937
Selling And Marketing Expenses91
Operating Expense6,0675,054
 
Net Interest Income (+$)
Interest Income5
Interest Expense-5
Other Finance Cost-103
Net Interest Income103
 
Pretax Income (+$)
Operating Income-6,124
Net Interest Income103
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-6,022-6,227
EBIT - interestExpense = -6,129
-6,022
-1,064
Interest Expense5
Earnings Before Interest and Taxes (EBIT)-6,124-6,017
Earnings Before Interest and Taxes (EBITDA)-6,067
 
After tax Income (+$)
Income Before Tax-6,022
Tax Provision-0
Net Income From Continuing Ops-1,069-6,022
Net Income-1,069
Net Income Applicable To Common Shares-1,069
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses6,124
Total Other Income/Expenses Net103-103
 

Technical Analysis of Neuroscientific
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neuroscientific. The general trend of Neuroscientific is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neuroscientific's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Neuroscientific Biopharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.071 < 0.071 < 0.071.

The bearish price targets are: 0.056 > 0.055 > 0.054.

Tweet this
Neuroscientific Biopharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Neuroscientific Biopharmaceuticals Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Neuroscientific Biopharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNeuroscientific Biopharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Neuroscientific Biopharmaceuticals Ltd. The current adx is .

Neuroscientific Biopharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartNeuroscientific Biopharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Stochastic Oscillator ChartNeuroscientific Biopharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartNeuroscientific Biopharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartNeuroscientific Biopharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Williams %R ChartNeuroscientific Biopharmaceuticals Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Average True Range (ATR) ChartNeuroscientific Biopharmaceuticals Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartNeuroscientific Biopharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd Daily Money Flow Index (MFI) ChartNeuroscientific Biopharmaceuticals Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Neuroscientific Biopharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Neuroscientific Biopharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Neuroscientific Biopharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.058
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neuroscientific with someone you think should read this too:
  • Are you bullish or bearish on Neuroscientific? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neuroscientific? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Neuroscientific Biopharmaceuticals Ltd

I send you an email if I find something interesting about Neuroscientific Biopharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Neuroscientific Biopharmaceuticals Ltd.

Receive notifications about Neuroscientific Biopharmaceuticals Ltd in your mailbox!